Sanofi SA Correlations
| SAN Stock | EUR 94.40 0.36 0.38% |
The current 90-days correlation between Sanofi SA and Air Liquide SA is 0.36 (i.e., Weak diversification). The correlation of Sanofi SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Sanofi SA Correlation With Market
Modest diversification
The correlation between Sanofi SA and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sanofi SA and DJI in the same portfolio, assuming nothing else is changed.
Sanofi |
The ability to find closely correlated positions to Sanofi SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sanofi SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sanofi SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sanofi SA to buy it.
Moving together with Sanofi Stock
Moving against Sanofi Stock
| 0.67 | ADOC | Adocia | PairCorr |
| 0.45 | PUB | Publicis Groupe SA | PairCorr |
| 0.44 | ATO | Atos SE | PairCorr |
| 0.38 | ALSGD | Spineguard | PairCorr |
| 0.31 | MLCMG | CMG Cleantech SA | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sanofi Stock performing well and Sanofi SA Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sanofi SA's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AI | 0.84 | (0.07) | 0.00 | (0.08) | 0.00 | 1.67 | 4.88 | |||
| CS | 0.68 | (0.04) | (0.10) | 0.04 | 1.05 | 1.22 | 4.27 | |||
| BN | 0.58 | 0.12 | (0.03) | (1.27) | 0.49 | 1.24 | 4.49 | |||
| DG | 0.83 | (0.09) | 0.00 | (0.15) | 0.00 | 2.04 | 7.20 | |||
| OR | 1.24 | (0.28) | 0.00 | (0.57) | 0.00 | 2.44 | 10.83 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sanofi SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Sanofi SA Corporate Management
Elected by the shareholders, the Sanofi SA's board of directors comprises two types of representatives: Sanofi SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sanofi. The board's role is to monitor Sanofi SA's management team and ensure that shareholders' interests are well served. Sanofi SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sanofi SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| JeanBaptiste Chatillon | Ex CFO | Profile | |
| Roy Papatheodorou | Gen VP | Profile | |
| Josephine Fubara | Chief Care | Profile | |
| Paul Hudson | CEO Director | Profile | |
| Bruno Mnard | Chief officer | Profile | |
| Pierre Chancel | Sr Marketing | Profile | |
| Laurent Gilhodes | Principal Accounting | Profile |